Efficacy of a Dedicated Therapeutic Education Program in Patients at High Cardiovascular Risk

University Hospital, Lille

Status

Completed

Conditions

High Blood Pressure

Treatments

Other: Therapeutic education HTA Vasc

Study type

Interventional

Funder types

Other

Identifiers

NCT01622400

2010-34

2011-A00333-38 (Other Identifier)

Details and patient eligibility

About

A dedicated therapeutic education program is an essential tool in the management of hypertension as well as in the control of other cardiovascular risk factors. The purpose of this study is therefore to evaluate the effect of such a therapeutic education program in general practice patients at high cardiovascular risk.

Full description

Current guidelines for the prevention of cardiovascular disease recognize the major interest of an optimal control of all cardiovascular risk factors. It includes high blood pressure reduction, dietetic measures (weight loss - control of dyslipidemia and diabetes - regular physical activity), smoking cessation, stress management, ... In that way, some authors suggest that it is essential for patients at high risk to have knowledge about their own pathology, medication, and to better understand the real benefit of specific lifestyle behaviors and the importance of blood pressure and glycaemia surveillance ... The aim of this randomized controlled trial is to evaluate the efficacy of a dedicated therapeutic education program to control blood pressure and other cardiovascular risk factors in general practice patients at high cardiovascular risk.

250 patients are being enrolled. All patients will receive standard care but only 125 patients (randomized 1 to 1) will receive a structured therapeutic education program.

Enrollment

240 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Man or woman of more than 18 years with a health insurance policy
General practice patients who are agree to participate of the program of patient's therapeutic education in Lille (59) or Arras (62)
Written informed consent must be obtained prior to performing any study-specific procedures
Patient at high cardiovascular risk (Patient with a high blood pressure and 3 cardiovascular risk factors and/or Patient with cardiovascular disease)

Exclusion criteria

Patient unwilling to take part to the therapeutic education program or to the study
Patient not suitable to participate in the therapeutic education program
Patient with dementia
Anticipated survival (due to comorbidities) of less than one year from baseline
Patient with current addiction or current alcohol / drug abuse
Patient with known plans to move to another area of the country
Unable to obtain written informed consent
Patient who are pregnant or lactating
Person without liberty by administrative or judiciary decision